MAIA Biotechnology, Inc.
  • About
    • About Us
    • Management
    • Board of Directors
    • Scientific Advisors
    • Advisors
    • Careers
  • Programs
    • Pipeline
    • Ateganosine (THIO) Program
    • Second-Generation Programs
    • Publications
  • Partners
  • Investors
  • Contact
  • Menu Menu
  • x
  • LinkedIn

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Analyst Coverage
    • Presentations
    • Contacts
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
May 05, 2025 11:45pm EDT

CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement

May 05, 2025 4:05pm EDT

MAIA Biotechnology Announces $1.08 Million Private Placement

Apr 01, 2025 8:30am EDT

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders

Mar 25, 2025 8:46am EDT

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025

Mar 20, 2025 9:20am EDT

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug

Mar 19, 2025 11:00am EDT

MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO

Feb 27, 2025 8:51am EST

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

Feb 26, 2025 8:47am EST

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

Feb 24, 2025 4:30pm EST

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million

Feb 18, 2025 3:44pm EST

MAIA Biotechnology Announces Private Placement of $2,715,000

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …11
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2025 - MAIA Biotechnology, Inc.     312.416.8592     |     info@maiabiotech.com     |     Terms of Use    |     Privacy Policy    |     Cookies Policy